Subscribe
Home
Daily Tape
Research Hub
Blog
About
Subscribe
Join 2,000+ investors
The biotech deal tape in your inbox. Free.
✓
Top news, M&A, BD&L, IPOs and VC — every morning
✓
Deal economics with investor-grade context
✓
Research Hub access: live trackers updated weekly
✓
5 minutes. Published every weekday.
Get the tape →
Latest Editions
Daily
Oct 9
Friday: Viatris pays $1.65B for Pacira's pain cash flows
Plus Zealand’s amylin data in diabetes, Tukysa moves up a line, and TRexBio prices at $14.
Oct 8
Thursday: argenx's $2.2B celiac bet pays off as Vyvgart misses
Plus Halozyme blocks SC Keytruda in eight countries, and Caribou pulls the plug.
Oct 7
Wednesday: Forbion banks €2.3B
Plus Epkinly's frontline DLBCL win and ArriVent's 57% plunge.
Oct 6
Tuesday: Vaxcyte rips, while $2B rare-disease M&A lands
Vaxcyte's pivotal print sent PCVX flying, Shionogi paid $2B for IntraBio, and Genentech bought Alector a runway.
Oct 5
Monday: CSL writes a $355M check for Alentis' kidney bet
Lilly takes Jaypirca first-line, and a sell-side desk crowns Genmab’s ovarian ADC.
